Intra-Cellular Therapies Inc. buy BiotechBee
Start price
24.06.23
/
70%
€58.60
Target price
30.06.26
€90.00
Performance (%)
18.43%
End price
19.02.24
€69.40
Summary
This prediction ended on 19.02.24 with a price of €69.40. The BUY prediction by BiotechBee finished with a performance of 18.43%. BiotechBee has a follow-up prediction for Intra-Cellular Therapies Inc. where he still thinks Intra-Cellular Therapies Inc. is a Buy. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intra-Cellular Therapies Inc. | 1.471% | 1.471% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
According to BiotechBee what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
In the thread Trading Intra-Cellular Therapies Inc.
Current prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.40
19.02.24
19.02.24
€85.00
30.09.25
30.09.25
-2.74%
16:05
16:05
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.49
23.09.22
23.09.22
€80.00
31.07.25
31.07.25
28.12%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year